MTOR and COVID-19: Thus, SARS‐CoV‐2 infection could lead to a hyper‐activation of hepatic mTOR signalling, via direct infection of hepatic cells, or indirect, cytokine storm‐related systemic IL‐6‐dependent effects, which could contribute to the steatotic phenotype in livers of COVID‐19 patients (Figure 2).